LEADER 02920nam 2200601 a 450 001 9910456504503321 005 20200520144314.0 010 $a1-61668-665-0 035 $a(CKB)2550000000010767 035 $a(EBL)3019921 035 $a(SSID)ssj0000412107 035 $a(PQKBManifestationID)12148424 035 $a(PQKBTitleCode)TC0000412107 035 $a(PQKBWorkID)10357937 035 $a(PQKB)10588763 035 $a(MiAaPQ)EBC3019921 035 $a(Au-PeEL)EBL3019921 035 $a(CaPaEBR)ebr10674929 035 $a(OCoLC)847615899 035 $a(EXLCZ)992550000000010767 100 $a20090520d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAromatase inhibitors$b[electronic resource] $etypes, mode of action and indications /$fJean R. Lamonte, editor 210 $aHauppauge, N.Y. $cNova Science Publishers$dc2009 215 $a1 online resource (203 p.) 225 1 $aCancer etiology, diagnosis and treatments series 300 $aDescription based upon print version of record. 311 $a1-60741-711-1 320 $aIncludes bibliographical references and index. 327 $aAnti-estrogen agents : aromatase inhibitors; past, present, and future / Masanori Shimodaira and Tomohiro Nakayama -- Aromatase inhibitors : types, mode of action, and indications / Helena Aguilar and Ander Urruticoechea -- Aromatase inhibitors / Mosammat Rashida Begum, Maruf Siddiqui -- Upfront vs. sequential aromatase inhibitors : an ongoing or settled debate? / Tallal Younis ... [et al.] -- Aromatase expression in the endometrium and its role in the development of uterine pathology / Hugo Maia Jr ... [et al.] -- Aromatase inhibitors for the medical treatment of endometriosis / Kaei Nasu ... [et al.] -- An update of the use of aromatase inhibitors in the management of breast cancer / S. Tang, D.A.L. Morgan, and K.L. Cheung -- Aromatase inhibitors in ovulation induction : myth or reality? / Nikolaos P. Polyzos ... [et al.] -- The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors / S.P. Langdon ... [et al.]. 410 0$aCancer etiology, diagnosis, and treatments series. 606 $aAromatase$xAntagonists$xTherapeutic use 606 $aEstrogen$xAntagonists$xTherapeutic use 606 $aBreast$xCancer$xChemotherapy 606 $aOvaries$xCancer$xChemotherapy 608 $aElectronic books. 615 0$aAromatase$xAntagonists$xTherapeutic use. 615 0$aEstrogen$xAntagonists$xTherapeutic use. 615 0$aBreast$xCancer$xChemotherapy. 615 0$aOvaries$xCancer$xChemotherapy. 676 $a616.99/449061 701 $aLamonte$b Jean R$0909495 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910456504503321 996 $aAromatase inhibitors$92035096 997 $aUNINA LEADER 01231nam a2200325 i 4500 001 991001326589707536 005 20020507191420.0 008 960920s1969 us ||| | eng 035 $ab10831976-39ule_inst 035 $aLE01310556$9ExL 040 $aDip.to Matematica$beng 082 0 $a512.2 084 $aAMS 20-06 084 $aAMS 20-XX 084 $aAMS 20A15 100 1 $aFolley, Karl W.$046867 245 10$aSemigroups :$bproceedings of a symposium on semigroups held at Wayne State University, Detroit, Michigan, June 27-29, 1968 /$cedited by Karl W. Folley 260 $aNew York :$bAcademic Press,$c1969 300 $axi, 277 p. :$bill. ;$c24 cm. 500 $aIncludes bibliographies. 500 $aSponsored by the National Science Foundation 650 4$aApplications of logic to the group theory 650 4$aGroup theory$xCongresses 650 4$aSemigroups-addresses, essays, lectures 907 $a.b10831976$b21-09-06$c28-06-02 912 $a991001326589707536 945 $aLE013 20-XX FOL11 (1969)$g1$i2013000060286$lle013$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i10941009$z28-06-02 996 $aSemigroups$9354097 997 $aUNISALENTO 998 $ale013$b01-01-96$cm$da $e-$feng$gus $h0$i1